Delving into the Latest Updates on Beijing Baiyi Wuyou Technology Development Co., Ltd. with Synapse

Overview

Tags

Infectious Diseases

Prophylactic vaccine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Infectious Diseases	1

Top 5 Drug Type	Count

Prophylactic vaccine	1

主要目的：评价接种1剂RSV疫苗（BW-201 (Adj 2)）后一个月（至D30）内的安全性和耐受性。次要目的：评价接种1剂RSV疫苗（BW-201 (Adj 2)）的体液免疫反应。评价接种1剂RSV疫苗（BW-201 (Adj 2)）的细胞免疫反应。评价接种1剂RSV疫苗（BW-201 (Adj 2)）在试验随访期间（至M12）的安全性。

[Translation]

Primary objectives: To evaluate the safety and tolerability of RSV vaccine (BW-201 (Adj 2)) within one month (to D30) after 1 dose. Secondary objectives: To evaluate the humoral immune response to 1 dose of RSV vaccine (BW-201 (Adj 2)). To evaluate the cellular immune response to 1 dose of RSV vaccine (BW-201 (Adj 2)). To evaluate the safety of 1 dose of RSV vaccine (BW-201 (Adj 2)) during the follow-up period (to M12).

Start Date-

Sponsor / Collaborator

Beijing Baiyi Wuyou Technology Development Co., Ltd.

CTR20251362

/ Not yet recruitingPhase 1

一项评价BW-201在18岁及以上健康成人中安全性、耐受性和免疫原性的随机、盲法、安慰剂对照的I期临床试验方案

[Translation] A randomized, blinded, placebo-controlled Phase I clinical trial to evaluate the safety, tolerability, and immunogenicity of BW-201 in healthy adults aged 18 years and older

主要目的: 评价接种1剂RSV疫苗(BW-201(Adi1))后一个月(至D30)内的安全性和耐受性。次要目的: 评价接种1剂RSV疫苗(BW-201(Adj1))的体液免疫反应。评价接种1剂RSV疫苗(BW-201(Adi1))的细胞免疫反应。评价接种1剂RSV疫苗(BW-201(Adi1))在试验随访期间(至M12)的安全性。

[Translation]

Primary objectives: To evaluate the safety and tolerability of RSV vaccine (BW-201(Adi1)) within one month (to D30) after 1 dose. Secondary objectives: To evaluate the humoral immune response to 1 dose of RSV vaccine (BW-201(Adj1)). To evaluate the cellular immune response to 1 dose of RSV vaccine (BW-201(Adi1)). To evaluate the safety of 1 dose of RSV vaccine (BW-201(Adi1)) during the follow-up period (to M12).

Start Date-

Sponsor / Collaborator

Beijing Baiyi Wuyou Technology Development Co., Ltd.

100 Clinical Results associated with Beijing Baiyi Wuyou Technology Development Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Beijing Baiyi Wuyou Technology Development Co., Ltd.

Login to view more data

100 Deals associated with Beijing Baiyi Wuyou Technology Development Co., Ltd.

Login to view more data

100 Translational Medicine associated with Beijing Baiyi Wuyou Technology Development Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 20 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

1

Login to view more data